ÂÜÀòÂÒÂ×

Christopher Wegerski is a seasoned professional in the pharmaceutical industry, currently serving as the Director of DMPK and Formulations at Atomwise since January 2023. Prior to this role, Christopher held the position of Associate Director in DMPK and Senior Scientist at eFFECTOR Therapeutics, Inc. from March 2014 to March 2024. Earlier experience includes roles as a Scientist at Lovelace Respiratory Research Institute from January 2010 to May 2013 and as a Preclinical and Pharmaceutical Sciences Scientist at SGX Pharmaceuticals between 2005 and 2008. Christopher obtained a Ph.D. in Natural Products Chemistry from the University of California, Santa Cruz, completing the degree from 1999 to 2005.